BellaSeno is advancing a bioresorbable scaffold platform designed to guide soft tissue formation at scale. Starting with breast applications, this approach supports the body’s own processes to generate, integrate, and adapt tissue over time.
.png)
Addressing silicone explant patients and soft-tissue defects through scaffold-guided restoration.
Provide temporary soft-tissue support designed to guide natural volume restoration over time.
Supporting soft-tissue restoration after mastectomy or lumpectomy through scaffold-guided natural regeneration over time.
Provides volume and shape while supporting the formation of the patient's own tissue.
Highly interconnected pores facilitate cell infiltration, vascularization, and tissue in-growth.
Engineered to resorb predictably over time, leaving behind viable, regenerated tissue.
Supports seamless integration with surrounding tissue for natural-feeling outcomes.
Designed for seamless integration into established surgical techniques.
Designed to provide temporary soft-tissue support of the patient’s own tissue.
A differentiated approach to unmet market needs in revision and post weight-loss procedures.
Built to generate long-term evidence on safety and effectiveness.
Successfully completed clinical feasibility evaluation.
Clinical study conducted across a 19-patient cohort.
Validated outcomes assessed through two-year follow-up.
Demonstrated sustained soft-tissue volume retention over time.
Prospective feasibility studies and initial safety evaluation.
Longitudinal follow-up and data maturation across indications.
Enabling future scalability across global markets.
Deutscher Platz 5A
04103 Leipzig
Germany
4 Starling Street
Burliegh Heads
QLD, Australia, 4220
